Intravenous methylprednisolone does not provide significant benefits over oral glucocorticoids for improving visual acuity or survival rates among patients with giant cell arteritis. Intravenous ...
A device that delivers a tyrosine kinase inhibitor can improve visual acuity and central subfield thickness in patients with diabetic macular edema, a 16-week phase 2 trial shows. Patients with ...